Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.10 | 5.94 |
PEG Ratio (TTM) | 0.09 | -0.51 |
P/S Ratio (TTM) | 0.29 | 5.47 |
P/B Ratio (TTM) | 0.30 | 17.80 |
P/FCF Ratio (TTM) | -1.19 | 15.71 |
Price to 5YR AVG Earnings Ratio | -0.06 | 25.36 |
Price to 5YR AVG FCF Ratio | -0.89 | 13.61 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -21.29% | 5.67% |
ROE (TTM) | -24.64% | 55.75% |
Net Profit Margin (TTM) | -26.52% | -132.78% |
ROIC 5YR AVG | -68.97% | -118.25% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -32.08% | 76.90% | 61.60% |
Revenue | 0.34% | 0.90% | -3.34% |
Net Income | -33.11% | -15.40% | 5.12% |
Cash Flow | -420.90% | -23.22% | -14.28% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.56 | 1.64 |
Quick Ratio (TTM) | 2.55 | 1.37 |
D/E Ratio (TTM) | 0.01 | 1.49 |
Interest Coverage (TTM) | -8.61 | 9.80 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 5.95 |
LTL to 5YR AVG FCF | -0.07 | 1.56 |
Shares Outstanding Growth 5YR AVG | 307.61% | 0.33% |